Automate Your Wheel Strategy on LFMD
With Tiblio's Option Bot, you can configure your own wheel strategy including LFMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LFMD
- Rev/Share 5.2351
- Book/Share 0.0086
- PB -149.4437
- Debt/Equity -12.3715
- CurrentRatio 0.7717
- ROIC 0.2657
- MktCap 284485391.0
- FreeCF/Share 0.2988
- PFCF 21.4462
- PE -39.734
- Debt/Assets 0.2998
- DivYield 0
- ROE 1.5486
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | LFMD | BTIG Research | -- | Buy | $15 | $18 | June 18, 2025 |
| Initiation | LFMD | Lake Street | -- | Buy | -- | $12 | Dec. 10, 2024 |
| Initiation | LFMD | Mizuho | -- | Neutral | -- | $7 | Dec. 4, 2024 |
| Resumed | LFMD | B. Riley Securities | -- | Buy | -- | $11 | Aug. 23, 2024 |
News
Shareholders of LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights – LFMD
Published: September 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
Published: September 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”)(NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
Published: September 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”)(NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
LifeMD, Inc. (LFMD) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: September 10, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Sept. 10, 2025 /PRNewswire/ -- The Law Offices of Frank R.
Read More
Deadline Alert: LifeMD, Inc. (LFMD) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: September 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 27, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”).
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
Published: September 08, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company")(NASDAQ: LFMD).
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
Published: September 08, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company")(NASDAQ: LFMD).
Read More
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: September 08, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Sept. 8, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ: LFMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Read More
Berger Montague PC Investigates Securities Claims Against LifeMD, Inc. (NASDAQ: LFMD)
Published: September 04, 2025 by: PRNewsWire
Sentiment: Neutral
PHILADELPHIA , Sept. 4, 2025 /PRNewswire/ -- Berger Montague PC , national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period").
Read More
LifeMD, Inc. (LFMD) Hit With Securities Class Action After Shares Crash 44% On Q2 2025 Earnings Surprise, Problems With Obesity Care and RexMD -- Hagens Berman
Published: September 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- A securities fraud class action lawsuit styled Johnston v.
Read More
ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LFMD
Published: September 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Published: September 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options
Read More
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
Published: September 01, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 1, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Class Period").
Read More
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: September 01, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 1, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ: LFMD) and certain of its officers.
Read More
LFMD Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against LifeMD, Inc.
Published: August 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired LifeMD, Inc. (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025. LifeMD is a leading provider of virtual primary care.
Read More
LifeMD, Inc. (LFMD) Hit With Securities Class Action After Shares Crash 44% On Q2 2025 Earnings Surprise, Problems With Obesity Care and RexMD -- Hagens Berman
Published: August 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- A securities fraud class action lawsuit styled Johnston v. LifeMD, Inc., et al.
Read More
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: August 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) and certain of its officers.
Read More
Law Offices of Howard G. Smith Encourages LifeMD, Inc. (LFMD) Investors To Inquire About Securities Fraud Class Action
Published: August 29, 2025 by: Business Wire
Sentiment: Neutral
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”). LifeMD investors have until October 27, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LIFEMD, INC. (LFMD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN T.
Read More
ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LFMD
Published: August 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 27, 2025 in the securities class action first filed by the Firm.
Read More
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (LFMD)
Published: August 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of all persons or entities who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”).
Read More
Faruqi & Faruqi Reminds LifeMD Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 27, 2025 - LFMD
Published: August 28, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 28, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD" or …
Read More
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of LifeMD, Inc. (LFMD) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
Published: August 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
ATLANTA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information, including allegations that: (1) Defendants materially overstated LifeMD's competitive position and (2) Defendants were reckless in raising LifeMD's 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and …
Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Published: August 27, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $LFMD #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) and reminds investors of the October 27, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has r.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeMD, Inc. - LFMD
Published: August 27, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeMD, Inc. - LFMD
Published: August 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
LFMD Investor News: If You Have Suffered Losses in LifeMD, Inc. (NASDAQ: LFMD), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Published: August 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeMD, Inc. - LFMD
Published: August 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
LFMD Investor News: Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation - LFMD
Published: August 14, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public. So What: If you purchased LifeMD securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation – LFMD
Published: August 13, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public. So What: If you purchased LifeMD securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rose.
Read More
Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive
HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.
Read More
About LifeMD, Inc. (LFMD)
- IPO Date 2008-01-29
- Website https://www.lifemd.com
- Industry Medical - Pharmaceuticals
- CEO Justin Schreiber
- Employees 304